89 related articles for article (PubMed ID: 14999240)
1. Relationship between upregulated oestrogen receptors and expression of growth factors in cultured, human, prostatic stromal cells exposed to estradiol or dihydrotestosterone.
Smith P; Rhodes NP; Ke Y; Foster CS
Prostate Cancer Prostatic Dis; 2004; 7(1):57-62. PubMed ID: 14999240
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol.
Smith P; Rhodes NP; Ke Y; Foster CS
Prostate Cancer Prostatic Dis; 2002; 5(2):105-10. PubMed ID: 12496997
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
4. [Effects of androgen and estrogen on the expressions of basic fibroblast growth factor, transforming growth factor and smoothelin].
Tang W; Zheng SB; Zhang JH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jan; 22(1):13-6. PubMed ID: 12390831
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
Ho CK; Nanda J; Chapman KE; Habib FK
J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
Arnold JT; Le H; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
[TBL] [Abstract][Full Text] [Related]
7. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
Jeyaraj DA; Udayakumar TS; Rajalakshmi M; Pal PC; Sharma RS
J Androl; 2000; 21(6):833-41. PubMed ID: 11105909
[TBL] [Abstract][Full Text] [Related]
9. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
10. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
12. Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP.
King KJ; Nicholson HD; Assinder SJ
Prostate; 2006 Jan; 66(1):105-14. PubMed ID: 16114065
[TBL] [Abstract][Full Text] [Related]
13. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
14. [The role of tissue steroids in benign hyperplasia and prostate cancer].
Voigt KD; Bartsch W
Urologe A; 1987 Nov; 26(6):349-57. PubMed ID: 2448941
[TBL] [Abstract][Full Text] [Related]
15. Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs.
Winter ML; Liehr JG
Toxicol Appl Pharmacol; 1996 Feb; 136(2):211-9. PubMed ID: 8619228
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
van der Poel HG
Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
[TBL] [Abstract][Full Text] [Related]
17. [Role of bFGF and TGF-beta1 in primary cultured prostatic stromal cells].
Gu H; Dong ZX; Wang CB; Yuan YF; Hou JH
Zhonghua Nan Ke Xue; 2006 Oct; 12(10):917-22. PubMed ID: 17121024
[TBL] [Abstract][Full Text] [Related]
18. Treatment with non-hypercalcemic analogs of 1,25-dihydroxyvitamin D3 increases responsiveness to 17beta-estradiol, dihydrotestosterone or raloxifene in primary human osteoblasts.
Katzburg S; Hendel D; Waisman A; Posner GH; Kaye AM; Somjen D
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):213-9. PubMed ID: 15084353
[TBL] [Abstract][Full Text] [Related]
19. Estrogen induction of smooth muscle differentiation of human prostatic stromal cells is mediated by transforming growth factor-beta.
Hong JH; Song C; Shin Y; Kim H; Cho SP; Kim WJ; Ahn H
J Urol; 2004 May; 171(5):1965-9. PubMed ID: 15076322
[TBL] [Abstract][Full Text] [Related]
20. [Physiopathological aspects of the treatment of benign prostatic hypertrophy. Role of prostatic stroma and estrogens].
Solè-Balcells F
J Urol (Paris); 1993; 99(6):303-6. PubMed ID: 7516373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
